Transdermal Research Pharm Laboratories

Transdermal Research Pharm Laboratories, LLC (TRPL) is a research and development company founded in 2013. Headquartered in Long Island City, New York, TRPL is a small company with four employees. TRPL specializes in developing transdermal drug delivery systems for both new chemical entities (NCEs) and existing approved drug products. Their expertise lies in creating topical and transdermal formulations tailored to specific disease models. TRPL offers its technology platforms to pharmaceutical companies seeking to deliver complex drugs through the skin, aiming to increase bioavailability through controlled and long-term release formulations. TRPL boasts a scientific staff with over 70 years of combined experience in transdermal drug delivery systems. The company has secured one patent, which has been out-licensed, and has submitted two additional patents currently available for licensing. Four more patents are in development. TRPL has successfully advanced three drug candidates into clinical trials, with two candidates completing Phase-I trials and currently under FDA review. Companies interested in partnering with TRPL can leverage their expertise and technology platforms. TRPL also offers fee-based contract services to pharmaceutical companies and investors, aiming to expedite the market entry of their products.